落子前
登录注册

Paul Hideyo Hayashi

United States Food and Drug Administration · University of North Carolina at Chapel Hill

4本站收录论文
42这些论文的被引
3本站 h 指数
12合作者

作者编号 A5061618111 · ORCID 0000-0002-5371-1020。统计只算本站收录的论文。

发表的论文4 篇，按出版时间

  1. 1
    R Value-Based Criteria Outperform Alkaline Phosphatase Less than Twice Normal in Identifying Hy’s Law Cases in Clinical TrialsDrug Safety20253
  2. 2
    Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver DiseasesDrug Safety20254
  3. 3
    Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline ValuesDrug Safety20246
  4. 4
    Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical TrialsDrug Safety202129

按月发文

2021.032024.042025.022025.08

逐年被引

202120222023202420252026

合作者

Eileen Navarro Almario3 篇Jasmine Amirzadegan2 篇Mark Avigan2 篇Bereket Tesfaldet2 篇Edwige Ymele Chiogo Vouffo1 篇Ling Lan1 篇Melissa Palmer1 篇Daniel W. Seekins1 篇Don C. Rockey1 篇John N Caminis1 篇Raúl J. Andrade1 篇Y. Veronica Pei1 篇

研究主题和期刊

Drug Safety4

意见反馈

页面出错、数据不对、想要什么功能，都可以告诉我们。

会附上你现在所在的页面地址，方便我们找到问题。